Save up -80% on Asparaginase Erwinia chrysanthemi
Note: this is a drug discount program, not an insurance plan.
2018 Price of Asparaginase Erwinia chrysanthemi
* price without discount in nearest pharmacy. Price may vary.
We offer free Asparaginase Erwinia chrysanthemi coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your discount card in most local pharmacies to get a discount on Asparaginase Erwinia chrysanthemi every time. What are you waiting for? Claim your prescription drug card now!
Asparaginase Erwinia chrysanthemi volume of distribution
5 L/m2. The partitioning of Erwinia L-asparaginase between lymph and blood shows that this enzyme, in contrast to the K coli derivative, does not penetrate the capillary endothelium well because negligible amounts are found in the lymph: hence, the drug seems to confine itself to the blood compartment of man.
Discount Cards 16,000+
Clients Benefit 29%
Total savings $4,735,080
What is Asparaginase Erwinia chrysanthemi
Erwinaze (asparaginase Erwiniachryanthemi) contains an asparaginase specific enzyme derived from Erwiniachrysanthemi. L-asparaginase is a tetrameric enzyme consisting of four identical subunits, each having a molecular weight of about 35 kDa. The activity of Erwinaze is expressed in terms of International Units. It is an antineoplastic agent and was FDA approved in November 19, 2011.
Asparaginase Erwinia chrysanthemi mechanism of action
Asparaginase Erwinia chrysanthemi catalyzes the deamidation of asparagine to aspartic acid and ammonia, resulting in a reduction in circulating levels of asparagine in the plasma. The mechanism of action of Erwinaze is thought to be based on the inability of leukemic cells to synthesize asparagine due to lack of asparagine synthetase activity, resulting in cytotoxicity specific for leukemic cells that depend on an exogenous source of the amino acid asparagine for their protein metabolism and survival.
Dosage forms of Asparaginase Erwinia chrysanthemi
|Injection, powder, lyophilized, for solution||intramuscular; intravenous||10000[iU]/mL|
Asparaginase (Erwinia) Asparaginase Erwinia chrysanthemi
Jazz Pharmaceuticals, Inc.
Humans and other mammals
Indication of Asparaginase Erwinia chrysanthemi
Asparaginase Erwinia chryanthemi is for the treatment of patients with acute lymphoblastic leukemia (ALL) that have developed a hypersensitivity to Escherichia coli-derivied asparaginase. It is a component of a multi-agent chemotherpeutic regimen for the treatment of the aforementioned disease and is considered second- or third- line treatment in European and American protocols.
Toxicity of Asparaginase Erwinia chrysanthemi
Because Erwinaze is injected intramuscularly, there is a higher chance of experiencing major skin reactions. Although the perceived benefit of Erwinia chryanthemi-derivied asparaginase is a lower incidence of hypersensitivity, there is still a chance that one may experience symptoms such as, but not limited to, anaphylaxis, pain, edema. Hypersensitivity to Erwinia chryanthemi-derivied asparaginase may be more likely if the patient had previously had an allergy to E.coli-derived asparaginase. Pancreatitis may also occur during the first few weeks of treatment with asparaginase. In addition, other severe adverse effects associated with Asparaginase Erwinia chrysanthemi are glucose intolerance as well as thrombosis and hemorrhage.
RX24 Drugs Disclaimer: before buying a Asparaginase Erwinia chrysanthemi on prescription, consult your healthcare provider. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.